Announced on | Meeting on |
Jul 25, 2024 | Aug 02, 2024 |
Quarterly Results | |
May 02, 2024 | May 10, 2024 |
Audited Results & Dividend | |
Jan 24, 2024 | Feb 02, 2024 |
Quarterly Results | |
Oct 27, 2023 | Nov 07, 2023 |
Quarterly Results | |
Jul 31, 2023 | Aug 08, 2023 |
Quarterly Results |
Hester Biosciences Share Price
- Open2,534.00
- High2,535.70
- Low2,465.05
- Prev Close2,498.85
- Volume4,187
- VWAP(₹)2,495.29
Hester Biosc share price insights
Employee & Interest Expense
Company has spent 6.49% of its operating revenues towards interest expenses and 21.06% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of 5.23% as compared to Nifty Smallcap 100 which gave a return of 84.96%. (as of last trading session)Hester Biosc Share Price Update
Hester Biosciences Ltd. share price moved down by -0.55% from its previous close of Rs 2,498.85. Hester Biosciences Ltd. stock last traded price is 2,485.20
Share Price Value Today/Current/Last 2,485.20 Previous Day 2,498.85
Hester Biosc Share Price Returns
1 Day | -0.55% |
1 Month | -10.66% |
3 Months | 44.38% |
1 Year | 40.12% |
3 Years | 4.66% |
5 Years | 53.96% |
Key Metrics
PE Ratio(x) | 109.00 |
EPS - TTM(₹) | 22.75 |
MCap(₹ Cr.) | 2,112.17 |
MCap Rank | 7 |
PB Ratio(x) | 7.02 |
Div Yield(%) | 0.24 |
Face Value(₹) | 10.00 |
52W High(₹) | 3,379.00 |
52W Low(₹) | 1,292.85 |
MCap/Sales | 3.88 |
Beta(1 Month) | 0.44 |
BV/Share(₹) | 356.04 |
Hester Biosc Share Recommendations
No Recommendations details available for this stock.
Check out other stock recos.
Hester Biosc News & Analysis
Hester Biosc Financials
Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023 Total Income 83.49 83.40 67.97 74.81 89.00 Total Income Growth (%) 0.11 22.70 -9.14 -15.94 26.26 Total Expenses 68.75 67.08 60.58 61.52 78.89 Total Expenses Growth (%) 2.50 10.73 -1.54 -22.01 29.35 EBIT 14.74 16.33 7.40 13.29 10.11 EBIT Growth (%) -9.70 120.73 -44.34 31.46 6.43 Profit after Tax (PAT) 6.34 4.95 3.98 4.09 5.87 PAT Growth (%) 28.00 24.25 -2.50 -30.38 29.53 EBIT Margin (%) 17.66 19.57 10.88 17.76 11.36 Net Profit Margin (%) 7.59 5.94 5.86 5.46 6.59 Basic EPS (₹) 8.80 7.52 4.73 4.75 7.89 All figures in Rs Cr, unless mentioned otherwise
InsightsEmployee & Interest Expense
Company has spent 6.49% of its operating revenues towards interest expenses and 21.06% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Total Assets 662.35 669.97 562.16 411.05 386.60 Total Assets Growth (%) -1.14 19.18 36.76 6.32 29.10 Total Liabilities 359.47 381.42 294.77 175.09 180.11 Total Liabilities Growth (%) -5.75 29.40 68.35 -2.79 52.25 Total Equity 302.88 288.55 267.39 235.96 206.49 Total Equity Growth (%) 4.97 7.91 13.32 14.27 13.99 Current Ratio (x) 2.03 1.53 2.01 2.63 1.91 Total Debt to Equity (x) 0.82 0.96 0.86 0.38 0.54 Contingent Liabilities 143.57 145.74 170.20 2.05 1.52 All figures in Rs Cr, unless mentioned otherwise
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Net Cash flow from Operating Activities 48.13 23.60 8.81 58.05 36.77 Net Cash used in Investing Activities -22.65 -77.00 -116.59 -38.37 -74.47 Net Cash flow from Financing Activities -26.05 41.76 111.61 -18.22 18.74 Net Cash Flow -0.41 -11.59 3.48 -2.26 -17.12 Closing Cash & Cash Equivalent 12.75 13.16 24.75 21.27 23.53 Closing Cash & Cash Equivalent Growth (%) -3.10 -46.84 16.37 -9.61 -42.11 Total Debt/ CFO (x) 4.97 11.36 25.27 1.48 2.96 All figures in Rs Cr, unless mentioned otherwise
InsightsDecrease in Cash from Investing
Company has used Rs 22.65 cr for investing activities which is an YoY decrease of 70.58%. (Source: Consolidated Financials)
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Return on Equity (%) 6.47 9.51 15.18 15.08 14.50 Return on Capital Employed (%) 8.46 8.64 12.28 17.16 16.06 Return on Assets (%) 2.85 3.97 7.02 8.37 7.54 Interest Coverage Ratio (x) 3.25 7.06 18.14 9.09 6.61 Asset Turnover Ratio (x) 0.46 0.43 0.53 52.14 47.40 Price to Earnings (x) 62.89 48.78 58.82 47.39 27.03 Price to Book (x) 4.05 4.62 8.88 7.14 3.91 EV/EBITDA (x) 22.03 23.66 34.11 23.22 14.21 EBITDA Margin (%) 21.11 24.71 31.37 34.21 33.70
Peer Comparison
NAME 1D 1W 1M 3M 1Y 3Y 5Y Hester Biosc Stock Performance -0.88 3.00 -18.86 49.04 42.06 4.31 53.69 All values in %
Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of 5.23% as compared to Nifty Smallcap 100 which gave a return of 84.96%. (as of last trading session)
Mutual Funds Ownership
MF Ownership as on 31 July 2024
Motilal Oswal BSE Healthcare ETF-G
Equity: Sectoral-Pharma
0.02
Amount Invested (in Cr.)
0.1%
% of AUM
-7.41
% Change (MoM basis)
Corporate Actions
Board Meeting
Quarterly Results
Jul 25, 2024
Final
60%
May 10, 2024
Board Meeting
Audited Results & Dividend
May 02, 2024
Announced on Ex-Date Dividend% May 10, 2024 Aug 22, 2024 60% May 17, 2023 Sep 13, 2023 80% May 20, 2022 Aug 11, 2022 100% Jun 08, 2021 Aug 05, 2021 100% Jun 26, 2020 Aug 27, 2020 66% Announced on Ex-Date Aug 14, 2012 Sep 27, 2012 Bonus Ratio: 1 share(s) for every 2 shares held No Data Available
Announced on Ex-Date Nov 15, 2005 May 29, 2006 Rights ratio: 2 share for every 5 held at a price of Rs 70.0 Announced on Meeting on Aug 23, 2023 Sep 20, 2023 Rs.8.0000 per share(80%)Final Dividend & A.G.M. Mar 28, 2023 May 02, 2023 - Jul 23, 2021 Aug 17, 2021 Book closure from Aug 7, 2021 to Aug 17, 2021 Jul 23, 2021 - Book closure from Aug 7, 2021 to Aug 17, 2021 Jul 23, 2021 - Book closure from Aug 7, 2021 to Aug 17, 2021
About
Hester Biosciences Ltd., incorporated in the year 1987, is a Small Cap company (having a market cap of Rs 2,125.74 Crore) operating in Agriculture/Horticulture/Livestock sector.
Hester Biosciences Ltd. key Products/Revenue Segments include Poultry & Poultry Farming, Other Operating Revenue and Export Incentives for the year ending 31-Mar-2024.
For the quarter ended 30-06-2024, the company has reported a Consolidated Total Income of Rs 83.49 Crore, up .11 % from last quarter Total Income of Rs 83.40 Crore and down 6.19 % from last year same quarter Total Income of Rs 89.00 Crore. Company has reported net profit after tax of Rs 6.63 Crore in latest quarter.
The company’s top management includes Dr.Bhupendra Gandhi, Mr.Rajiv Gandhi, Ms.Priya Gandhi, Mr.Ameet Desai, Mr.Anil Jain, Mr.Ashok Bhadakal, Mr.Jatin Trivedi, Ms.Sandhya Patel, Mr.Ravin Gandhi, Mr.Sanjiv Gandhi, Ms.Nina Gandhi, Mr.Nikhil Jhanwar, Mr.Vinod Mali. Company has Chandulal M Shah & Co. as its auditors. As on 30-06-2024, the company has a total of .85 Crore shares outstanding.
About Hester Biosc
Hester Biosciences Ltd., incorporated in the year 1987, is a Small Cap company (having a market cap of Rs 2,125.74 Crore) operating in Agriculture/Horticulture/Livestock sector. Hester Biosciences Ltd. key Products/Revenue Segments include Poultry & Poultry Farming, Other Operating Revenue and Export Incentives for the year ending 31-Mar-2024.For the quarter ended 30-06-2024, the company has reported a Consolidated Total Income of Rs 83.49 Crore, up .11 % from last quarter Total Income of Rs 83.40 Crore and down 6.19 % from last year same quarter Total Income of Rs 89.00 Crore. Company has reported net profit after tax of Rs 6.63 Crore in latest quarter.The company’s top management includes Dr.Bhupendra Gandhi, Mr.Rajiv Gandhi, Ms.Priya Gandhi, Mr.Ameet Desai, Mr.Anil Jain, Mr.Ashok Bhadakal, Mr.Jatin Trivedi, Ms.Sandhya Patel, Mr.Ravin Gandhi, Mr.Sanjiv Gandhi, Ms.Nina Gandhi, Mr.Nikhil Jhanwar, Mr.Vinod Mali. Company has Chandulal M Shah & Co. as its auditors. As on 30-06-2024, the company has a total of .85 Crore shares outstanding.
Industry
Key Indices Listed On
BSE SmallCap, BSE Healthcare, BSE AllCap, BSE MidSmallCap
Address
�Pushpak� 1st Floor,Panchvati Circle,Motilal Hirabhai Road,Ahmedabad, Gujarat - 380006
Executive Leadership
Bhupendra Gandhi
ChairmanRajiv Gandhi
Managing Director & CEOPriya Gandhi
Executive DirectorAmeet Desai
Independent DirectorAuditors
Trending in Markets
DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.